- Home
- BARK vs CRDF Comparison
BARK vs CRDF Comparison
Compare BARK & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- CRDF
- Stock Information
- Founded
- BARK 2011
- CRDF 1999
- Country
- BARK United States
- CRDF United States
- Employees
- BARK N/A
- CRDF N/A
- Industry
- BARK Department/Specialty Retail Stores
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BARK Consumer Discretionary
- CRDF Health Care
- Exchange
- BARK Nasdaq
- CRDF Nasdaq
- Market Cap
- BARK 244.9M
- CRDF 196.2M
- IPO Year
- BARK N/A
- CRDF N/A
- Fundamental
- Price
- BARK $1.16
- CRDF $2.66
- Analyst Decision
- BARK Buy
- CRDF Strong Buy
- Analyst Count
- BARK 2
- CRDF 4
- Target Price
- BARK $2.50
- CRDF $12.25
- AVG Volume (30 Days)
- BARK 542.2K
- CRDF 1.1M
- Earning Date
- BARK 06-02-2025
- CRDF 05-08-2025
- Dividend Yield
- BARK N/A
- CRDF N/A
- EPS Growth
- BARK N/A
- CRDF N/A
- EPS
- BARK N/A
- CRDF N/A
- Revenue
- BARK $490,256,000.00
- CRDF $587,000.00
- Revenue This Year
- BARK $3.12
- CRDF N/A
- Revenue Next Year
- BARK $7.76
- CRDF N/A
- P/E Ratio
- BARK N/A
- CRDF N/A
- Revenue Growth
- BARK N/A
- CRDF N/A
- 52 Week Low
- BARK $1.09
- CRDF $2.01
- 52 Week High
- BARK $2.56
- CRDF $5.64
- Technical
- Relative Strength Index (RSI)
- BARK 39.07
- CRDF 42.40
- Support Level
- BARK $1.09
- CRDF $2.42
- Resistance Level
- BARK $1.15
- CRDF $2.87
- Average True Range (ATR)
- BARK 0.05
- CRDF 0.19
- MACD
- BARK 0.01
- CRDF 0.01
- Stochastic Oscillator
- BARK 36.84
- CRDF 27.91
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.